Dipna Pharmachem Ltd has rescheduled its board meeting to July 2, 2026, to consider the audited financial results for the half year and year ended March 31, 2026. The meeting, initially convened on July 1, 2026, was adjourned to facilitate a thorough review of the financial performance and the accompanying Auditor's Report. The decision was taken during the board meeting held on July 1, 2026, at the company's registered office in Ahmedabad.

The rescheduled meeting will be held on July 2, 2026, at 4:00 P.M. at the registered office located at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad – 380 055. The primary agenda includes the discussion and approval of the audited financial results for the specified periods. Additionally, any other matter with the permission of the chairperson may be taken up for consideration.

The board meeting on July 1, 2026, commenced at 4:00 P.M. and concluded at 7:00 P.M. The decision to reschedule was communicated to BSE Limited pursuant to Regulation 30(6) of the SEBI (LODR) Regulations, 2015. The intimation was signed by Keyur Dipakkumar Shah, Managing Director of Dipna Pharmachem Ltd.

The audited financial results for the half year and year ended March 31, 2026, along with the Auditor's Report, are key items on the agenda. The outcome of the meeting will provide insights into the company's financial performance for the reported periods. Shareholders and investors are advised to await the official announcement post-meeting.

Meeting Details

The company has ensured compliance with regulatory requirements by intimating the exchange about the rescheduling. The audited financial results, once approved, will be disclosed in accordance with applicable regulations.

Dipna Pharmachem Limited has announced the outcome of its postal ballot process for the appointment of a secretarial auditor for the financial year 2025-26. The company sought shareholder approval for the appointment of M/s. Jay Pandya & Associates, Company Secretaries, Ahmedabad, through an ordinary resolution. The remote e-voting period concluded on May 22, 2026.

The resolution was approved with the requisite majority by the shareholders. The scrutinizer's report confirmed the outcome, detailing the votes cast in favour and against the proposal. The appointment is effective for the specified financial year.

Voting Results

The postal ballot results indicate strong shareholder support for the resolution. A total of 2,652,450 valid votes were cast, with the majority favouring the appointment.

Process Details

The remote e-voting process was conducted in compliance with the provisions of Section 108 and 110 of the Companies Act, 2013, and relevant SEBI regulations. The e-voting period was open from April 23, 2026, to May 22, 2026. The cut-off date for determining shareholder eligibility was April 17, 2026. M/s. Jay Pandya & Associates acted as the scrutinizer for the process.